earnings

This Is the Most Important Number From Novavax's Q1 Earnings
Motley Fool
Fri, 05/13/22 - 10:40 am
Novavax
earnings
vaccines
COVID-19
Takeda Drops One Hunter Syndrome Therapeutic, Puts Faith in Another
BioSpace
Thu, 05/12/22 - 10:21 am
Takeda
earnings
TAK-609
Hunter Syndrome
Ascendis Slammed After Growth Hormone Drug Faces An Unexpected Challenge
Investors Business Daily
Thu, 05/12/22 - 10:18 am
Ascendis Pharma
Skytrofa
earnings
Is Regeneron In Trouble After Sales Declined 40% In a Single Quarter?
Motley Fool
Thu, 05/12/22 - 10:15 am
Regeneron
earnings
Takeda, bracing for Vyvanse patent loss, makes strides on debt goal and pivots its focus to launches
Fierce Pharma
Wed, 05/11/22 - 10:49 am
Takeda
debt
Vyvanse
patents
earnings
FDA hits Amicus with delay on 'breakthrough' Pompe drug
Endpoints
Wed, 05/11/22 - 10:34 am
Amicus Therapeutics
Pompe disease
earnings
AT-GAA
Bayer's farming business drives Q1 earnings beat
Yahoo/Reuters
Tue, 05/10/22 - 10:53 am
Bayer
earnings
After racking up 41 Covid jab nods outside US, Novavax hits first profitable quarter but still disappoints investors
Endpoints
Tue, 05/10/22 - 10:48 am
Novavax
COVID-19
earnings
vaccines
Medtech earnings week 3: Procedure rebounds, stock price declines, iRhythm’s comeback
Medtech Dive
Tue, 05/10/22 - 10:38 am
Medtech
devices
earnings
AtriCure
Axonics
iRhythm Technologies
BioNTech's Q1 vaccine sales triple but it still flags full-year decline
Yahoo/Reuters
Mon, 05/9/22 - 10:35 am
BioNTech
earnings
vaccines
Pfizer
COVID-19
The COVID pandemic has affected biopharma companies disparately
BioSpace
Sun, 05/8/22 - 12:29 pm
COVID-19
pandemic
earnings
biotech
Is Gilead Sciences Too Dependent On These 2 Areas of Its Business?
Motley Fool
Sun, 05/8/22 - 12:17 pm
Gilead Sciences
COVID-19
Veklury
earnings
HIV
BioCryst's Orladeyo Launch Overshadowed by FDA Hold on PNH Asset
BioSpace
Sun, 05/8/22 - 12:09 pm
Biocryst
Orladeyo
earnings
BCX9930
BeiGene Reports Lucrative Q1 Amid SEC Audit
BioSpace
Sun, 05/8/22 - 12:08 pm
BeiGene
earnings
In wake of Biogen's skirmish with the SEC, pharma giants are changing the way they do quarterly reports
Endpoints
Thu, 05/5/22 - 11:34 pm
Biogen
earnings
SEC
Eli Lilly
Merck
Bristol Myers Squibb
Pfizer
AbbVie
Why Intuitive Surgical Stock Dropped 20.7% in April
Motley Fool
Thu, 05/5/22 - 11:13 pm
Intuitive Surgical
robotic surgery
earnings
Pfizer Is Poised to Shatter These 2 Records in 2022
Motley Fool
Thu, 05/5/22 - 10:41 am
Pfizer
earnings
Paxlovid
Amarin, after 33% revenue decline, aims to 'stabilize' US sales and grow in Europe
Fierce Pharma
Thu, 05/5/22 - 10:21 am
Amarin
earnings
Regeneron tries to shake off fall in COVID drug sales with first quarter earnings
BioPharma Dive
Wed, 05/4/22 - 05:44 pm
Regeneron
earnings
Zimmer Biomet Beats Analyst Expectations in Q1
Medical Devices and Diagnostics Industry
Wed, 05/4/22 - 05:32 pm
Zimmer Biomet
earnings
Medtech
devices

Pages